PillRx only · For Suspension · Oral
Oseltamivir Phosphate
Oseltamivir Phosphate
9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US11 NDCs
9 active makers
9 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.153
Latest avg · Jul 22, 2026
-10%
Since Dec 17, 2025
9
Active US suppliers
36%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
540K
Rx · 2026 Q1
56.1M
Units dispensed
-31%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it9 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Preferred Pharmaceuticals Inc. | unknown | 2 | SUPPLYING |
| Alembic Pharmaceuticals Limited | unknown | 2 | SUPPLYING |
| Ajanta Pharma USA Inc. | unknown | 1 | SUPPLYING |
| Amneal Pharmaceuticals LLC | unknown | 1 | SUPPLYING |
| NuCare Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | unknown | 1 | SUPPLYING |
| AvKARE | unknown | 1 | SUPPLYING |
| Cipla USA Inc. | unknown | 1 | SUPPLYING |
| Exelan Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Feb 13, 2024RECALLRecall (Class II): Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmace…
Failed Impurities/Degradation Specifications: Out-of-specification test results. — Recalling firm: Amneal Pharmaceuticals of New York, LLC — Nationwide in the USA